Skip to main content
SpringerLink
Log in

Absorption of Propranolol in Humans Following Oral, Jejunal, and Heal Administration

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. J. T. Fell and G. A. Digenis. Imaging and behaviour of oral dosage forms in vivo. Int. J. Pharm. 22:1-15 (1984).

    Google Scholar 

  2. G. Jobin, A. Corot, J. Godbillon, M. Duval, J. P. Schoeller, J. Hirtz, and J. J. Bernier. Investigation of drug absorption from the gastrointestinal tract of man. I. Metoprolol in stomach, duodenum and jejunum. Br. J. Clin. Pharmacol. 19:97S-105S (1985).

    Google Scholar 

  3. N. Vidon, D. Evard, J. Godbillon, M. Rongier, M. Duval, J. P. Schoeller, J. J. Bernier, and J. Hirtz. Investigation of drug absorption from the gastrointestinal tract of man. II. Metoprolol in the jejunum and ileum. Br. J. Clin. Pharmacol. 19:107S-112S (1985).

    Google Scholar 

  4. D. Gardner, R. Casper, F. Leith, and I. Wilding. Noninvasive methodology for assessing regional drug absorption from the gastrointestinal tract. Pharm. Technol. 21:82-89 (1997).

    Google Scholar 

  5. H. Leneernas, O. Ahrenstedt, R. Hallgren, L. Knutson, M. Ryde, and L. K. Paalzow. Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man. Pharm. Res. 10:1243-1251 (1992).

    Google Scholar 

  6. D. J. Schuirmann. A comparison of the two one-sided tests procedure and the power approach for assessing equivalence of average bioavailability. J. Pharmacokinetic Biopharm. 6:657-680 (1987).

    Google Scholar 

  7. W. H. Barr, E. M. Zola, E. L. Candler, S-M. Hwang, A. V. Tendolkar, R. Shamburek, B. Parker, and M. Hilty. Differential absorption of amoxicillin from the human small and large intestine. Clin. Pharm. Ther. 56:279-285 (1994).

    Google Scholar 

  8. K. K. H. Chan, A. B. Buch, R. D. Glazer, V. A. John, and W. H. Barr; Site-differential gastrointestinal absorption of benazepril hydrochloride in healthy volunteers. Pharm. Res. 11:432-437 (1994).

    Google Scholar 

  9. M. F. Williams, G. E. Dukes, W. Heizer, Y.-H. Han, D. J. Hermann, T. Lampkin, and L. J. Hak. Influence of gastrointestinal site of drug delivery on the absorption characteristics of ranitidine. Pharm. Res. 9:1190-1196 (1992).

    Google Scholar 

  10. P. E. Warner, K. L. R. Brouwer, E. K. Hussey, G. E. Dukes, W. D. Heizer, K. H. Donn, I. M. Davis, and J. R. Powell. Sumitriptan absorption from different regions of the human gastrointestinal tract. Pharm. Res. 12:138-143 (1995).

    Google Scholar 

  11. W. N. Charman, M. C. Rogge, A. W. Boddy, W. H. Barr, and B. M. Berger. Absorption of danazol after administration to different sites of the gastrointestinal tract and the relationship to single-and double-peak phenomena in the plasma profiles. J. Clin. Pharmacol. 33:1207-1213 (1993).

    Google Scholar 

  12. L. K. Tay, F. Dixon, Jr., M. B. Sostrin, W. H. Barr, R. H. Farmen, and K. A. Pittman. The site differential gastrointestinal absorption of gepirone in humans. J. Clin. Pharmacol. 32:827-832 (1992).

    Google Scholar 

  13. W. Homsy, G. Caille, and P du Souich. The site of absorption in the small intestine determines diltiazem bioavailability in the rabbit. Pharm. Res. 12:1722-1726 (1995).

    Google Scholar 

  14. W. H. Barr. The role of intestinal metabolism on bioavailability. In P. G. Welling, F. L. S. Tse, and S. V. Dighe (eds). Pharmaceutical Bioequivalence, Marcel Dekker, New York, 1991, pp. 149-168.

    Google Scholar 

  15. D. C. Taylor, R. Grundy, and B. Loveday. Chronic dog intestinal loop model for studying drug absorption as exemplified by beta-adrenoreceptor blocking agents, atenolol and propranolol. J. Pharm. Sci. 70:516-521 (1981).

    Google Scholar 

  16. C. M. Castleden, C. F. George, and M. D. Short. Contribution of individual differences in gastric emptying to variability in plasma propranolol concentrations. Br. J. Clin. Pharmacol. 5:121-122 (1978).

    Google Scholar 

  17. T. Walle, U. K. Walle, and L. S. Olanoff. Quantitative account of propranolol metabolism in urine of normal man. Drug Metab. Disp. 13:204-209 (1985).

    Google Scholar 

  18. E. Diczfalusy, C. Franksson, and B. Martinsen. Oestrogen conjugation by the human intestinal tract. Acta Endocrin. 38:59-72 (1961).

    Google Scholar 

  19. P. Du Souich, H. Maurice, and L. Heroux. Contribution of the small intestine to the first-pass uptake and systemic clearance of propranolol in rabbits. Drug Metab. Disp. 23:279-284 (1995).

    Google Scholar 

  20. D. R. Krishna and U. Klotz. Extrahepatic metabolism of drugs in humans. Clin. Pharmacokinet. 26:144-160 (1994).

    Google Scholar 

Download references

Author information

Author notes

  1. Akshay Buch

    Present address: Procter and Gamble Pharmaceuticals, Cincinnati, Ohio

Authors and Affiliations

  1. Department of Pharmacy and Pharmaceutics, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia

    Akshay Buch & William H. Barr

Authors
  1. Akshay Buch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William H. Barr
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buch, A., Barr, W.H. Absorption of Propranolol in Humans Following Oral, Jejunal, and Heal Administration. Pharm Res 15, 953–957 (1998). https://doi.org/10.1023/A:1011997120293

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011997120293

Search

Navigation